Posted on May 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on November 1, 202111/1/21
The Need for RWE Studies in APAC and the Impact on Product Life Cycle Management
Posted on September 17, 20219/17/21
Measuring the Impact of Coordinated Field and Digital Engagement Through Network Influence: An Omnichannel Case Study
Posted on July 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on June 15, 20216/15/21
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
Posted on June 14, 20216/14/21
Omnichannel: A Conversation With the Innovators
Posted on April 26, 20214/26/21
Ask the Expert: How to Maximize Your Omnichannel Strategy
Posted on March 29, 20213/29/21
Turning Theory Into Action: How Real-World Evidence Drives Clinical Research and Improves Patient Outcomes
Posted on March 15, 20213/15/21
BLOG: Not So Rare… The True Impact of Rare Diseases
Posted on February 24, 20212/24/21